David Jablons, MD

Chief of Thoracic Surgery

Dr. David M. Jablons is a renowned lung cancer expert, chief of General Thoracic Surgery at UCSF Medical Center and program leader of the Thoracic Oncology Program of the UCSF Helen Diller Family Comprehensive Cancer Center. He also is director of the UCSF Thoracic Oncology Laboratory where he is investigating molecular biology and genomics.

Jablons earned an undergraduate degree from Yale University and a medical degree from Albany Medical College of Union University. He completed a surgical residency at Tufts-New England Medical Center. He has written numerous research papers and frequently lectures about lung cancer at international and national meetings. He is a member of many professional organizations, including the American Association for Cancer Research, International Association for the Study of Lung Cancer, Society of Thoracic Surgeons and the American Association for the Advancement of Science.

Clinics

Thoracic Surgery and Oncology
1600 Divisadero St., Fourth Floor
San Francisco, CA 94143-1705
Phone: (415) 885-3882
Fax: (415) 353-7151

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

Board Certification

Thoracic and Cardiac Surgery, American Board of Thoracic Surgery

Academic Title

Professor

More about David Jablons

Additional Languages

Chinese
French
Russian
Spanish

Education

Albany Medical College 1984

Residencies

Tufts-New England Medical Center, General Surgery 1991

Fellowships

New York Hospital-Cornell University, Cardiothoracic Surgery 1993

Selected Research and Publications

  1. Li T, Zhang W, Xu Q, Li S, Tong X, Ding J, Li H, Hou S, Xu Z, Jablons DM, You L. Transfer of multiple loci of donor's genes to induce recipient tolerance in organ transplantation. Exp Ther Med. 2018 Jun; 15(6):4961-4971.
  2. Hsu PC, Miao J, Wang YC, Zhang WQ, Yang YL, Wang CW, Yang CT, Huang Z, You J, Xu Z, Jablons DM, You L. Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma. J Cell Mol Med. 2018 Mar 24.
  3. Hsu PC, Miao J, Huang Z, Yang YL, Xu Z, You J, Dai Y, Yeh CC, Chan G, Liu S, Urisman A, Yang CT, Jablons DM, You L. Inhibition of yes-associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model. J Cell Mol Med. 2018 Mar 24.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.